ABCL

AbCellera Biologics Inc.

Price

$11.13

return (12m)

142.48%

p/e

-20.68

p/bv

3.80

DIVIDEND YIELD

0.00%

ABCL price

AbCellera Biologics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ABCL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

72.42%

3 months

172.13%

1 year

142.48%

2 years

324.81%

5 years

-36.98%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ABCL

Valuation

P/E

-20.68

Sector -16.77

Industry -542.93

P/BV

3.80

Sector 1.33

Industry -1.48

P/Revenue (PSR)

51.47

Sector 1.74

Industry 2.32

EV/EBITDA

-57.15

Sector -36,649,845.16

Industry -29,372,015.96

EV/EBIT

-48.64

Sector -39,124,687.16

Industry -17,927,541.69

P/EBITDA

-19.10

Sector -13.53

Industry -545.71

P/EBIT

-16.15

Sector -19.09

Industry -62.85

P/Total Assets

2.60

Sector 0.96

Industry 1.00

P/Net Current Assets

12.72

Sector -6,133,215.93

Industry -1,187,396.77

P/Working Capital

5.44

Sector 1,244,144.76

Industry -5,342,392.62

EPS

-0.54

Sector -2.25

Industry -6.17

BVPS

2.93

Sector 2.92

Industry 1.18

Efficiency

Gross Margin

100.00%

Sector 34.79%

Industry 30.82%

EBITDA Margin

-1,238.02%

Sector -323.65%

Industry -17,123,256.17%

EBIT Margin

-1,454.81%

Sector -194.57%

Industry -17,075,723.02%

Operating Margin

-100.00%

Sector -35.50%

Industry -43.99%

Net Profit Margins

-100.00%

Sector -39.54%

Industry -46.61%

Asset Turnover

0.00

Sector 0.12

Industry 0.06

Profitability

ROE

-18.38%

Sector -86.07%

Industry -480.14%

ROA

-12.59%

Sector -58.03%

Industry -120.67%

ROIC

-29.02%

Sector -431.16%

Industry -495.58%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

12.77

Sector 1.84

Industry 2.30

Net Debt / EBITDA

10.77

Sector -1.47

Industry -4.06

Net Debt / EBIT

9.17

Sector -1.32

Industry -5.44

Net Debt / Equity

-0.60

Sector -0.35

Industry -0.96

Gross Debt / Equity

0.00

Sector 0.14

Industry -0.53

Equity/Assets

0.69

Sector 0.27

Industry 0.19

Liabilities/Assets

0.31

Sector 0.36

Industry 0.21

Growth

5Y Revenue CAGR

540.67%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ABCL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ABCL AbCellera Biologics Inc.	$11.13	143.01%	0.00%	-20.68	3.80	-18.38%	-100.00%
LLY Eli Lilly and Compay	$1,188.21	75.10%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$399.79	-17.12%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$43.70	-6.81%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$151.17	27.15%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$593.60	22.98%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$111.78	-11.16%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.82	2.03%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$49.23	31.54%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$97.41	52.48%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.52	-48.77%	0.00%	18.98	0.00	-%	19.57%
IDXX IDEXX Laboratories Inc.	$552.82	-16.73%	0.00%	38.32	27.08	70.67%	25.03%
TMDX TransMedics Group Inc.	$88.25	-33.17%	0.00%	20.36	5.96	29.28%	22.69%
RMD ResMed Inc.	$225.48	-20.77%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$203.38	-2.54%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$406.18	4.71%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$325.76	185.73%	0.00%	79.32	5.68	7.16%	11.31%
SYK Stryker Corp.	$340.48	-9.00%	1.02%	34.97	5.44	15.55%	14.43%
PHG Koninklijke Philips NV	$27.36	4.21%	3.70%	20.19	1.98	9.80%	6.30%
INMD InMode Ltd.	$15.17	3.52%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ABCL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT AbCellera Biologics

AbCellera Biologics Inc.

Average Investor10 user rating

4.0 (7 people)

United States

14 years

Founded: 2012

2020

Time since IPO - 6 years

206

Employees

AbCellera Biologics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.41 billion, with shareholders equity totaling $896.02 million.

The company employs approximately 206 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, AbCellera Biologics Inc. reported $66.17 million in revenue, generating net income of $-164.66 million.

Key financial metrics include a P/E ratio of -20.68, a price-to-book (P/B) ratio of 3.80, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ABCL.

Market cap

$3.41 billion

Net worth

$896.02 million

$896,020,000.00

Assets

$1.31 billion

$1,307,580,000.00

Total Shares Outstanding

306.00 million

306,000,000

Average Daily Trading Volume

$8.05 million

$8,054,198.00

Sector

Health

Industry

Life Science Tools and Services

ABCL

ABCL revenue and profits

Financial Results ABCL

DRAG THE FRAME TO SEE MORE DATA

ABCL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.41 46,48% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$281.76 --2,99% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$66.90 134,82% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$385.88 36,69% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$43.70 --8,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,188.21 71,43% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$406.18 3,30% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$151.17 24,07% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87